252 related articles for article (PubMed ID: 36995521)
1. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
[TBL] [Abstract][Full Text] [Related]
2. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
Liang W; Wang C; Wang J; Zhang M
Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma
Hu DX; Sun QF; Xu L; Lu HD; Zhang F; Li ZM; Zhang MY
World J Gastroenterol; 2022 Jan; 28(4):464-478. PubMed ID: 35125830
[TBL] [Abstract][Full Text] [Related]
4. PLCD3 promotes malignant cell behaviors in esophageal squamous cell carcinoma via the PI3K/AKT/P21 signaling.
Wang M; Gao M; Chen Y; Wu J; Wang X; Shu Y
BMC Cancer; 2023 Sep; 23(1):921. PubMed ID: 37773107
[TBL] [Abstract][Full Text] [Related]
5. β-elemene Suppresses Migration of Esophageal Squamous Cell Carcinoma by Modulating Expression of MMP9 through the PI3K/Akt/NF-κB Pathway.
Liang Y; Li S
Comb Chem High Throughput Screen; 2023; 26(13):2304-2320. PubMed ID: 36872359
[TBL] [Abstract][Full Text] [Related]
6. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
Li B; Xu WW; Lam AKY; Wang Y; Hu HF; Guan XY; Qin YR; Saremi N; Tsao SW; He QY; Cheung ALM
Oncotarget; 2017 Jun; 8(24):38755-38766. PubMed ID: 28418888
[TBL] [Abstract][Full Text] [Related]
7. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
[TBL] [Abstract][Full Text] [Related]
8. COL8A1 Regulates Esophageal Squamous Carcinoma Proliferation and Invasion Through PI3K/AKT Pathway.
Hu J; Li P; Dan Y; Chen Z; Lu Y; Chen X; Yan S
Ann Surg Oncol; 2024 May; 31(5):3502-3512. PubMed ID: 38429534
[TBL] [Abstract][Full Text] [Related]
9. Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway.
Qiao Z; Dai C; Wang Z; Wang Z; Wang Z; Zhang T; Niu W; Ma X
Thorac Cancer; 2022 Apr; 13(8):1117-1125. PubMed ID: 35238170
[TBL] [Abstract][Full Text] [Related]
10. E2F1-activated NRSN2 promotes esophageal squamous cell carcinoma progression through AKT/mTOR pathway.
Yan Z; Xu T; Lu J; Wu Z; Li X; Xu J; Guo W; Dong Z
Pathol Res Pract; 2022 Aug; 236():153963. PubMed ID: 35662041
[TBL] [Abstract][Full Text] [Related]
11. PHLDA3 activated by BARX2 transcription, suppresses the malignant development of esophageal squamous cell carcinoma by downregulating PI3K/AKT levels.
Chen S; Lin X; He R; Zhang W; Kang M; Xu R
Exp Cell Res; 2023 May; 426(2):113567. PubMed ID: 36965748
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
[TBL] [Abstract][Full Text] [Related]
13. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
Fan ZL; Yang LY; Zhang N; Feng D; Guo J; Chang C; Yuan Q; Cai Y; Zhang Y; Wei WQ; Wang MR; Hao JJ
Yi Chuan; 2022 Apr; 44(4):322-334. PubMed ID: 35437240
[TBL] [Abstract][Full Text] [Related]
14. CircPDE5A-encoded novel regulator of the PI3K/AKT pathway inhibits esophageal squamous cell carcinoma progression by promoting USP14-mediated de-ubiquitination of PIK3IP1.
Lei K; Liang R; Liang J; Lu N; Huang J; Xu K; Tan B; Wang K; Liang Y; Wang W; Lin H; Wang M
J Exp Clin Cancer Res; 2024 Apr; 43(1):124. PubMed ID: 38658954
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of fibulin-4 inhibits autophagy and promotes the sensitivity of esophageal squamous cell carcinoma cells to apatinib by activating the Akt-mTOR signaling pathway.
Chen X; Wang J; Song L; Yu Y; Shi M; Jiang W; Liu X; He X
Thorac Cancer; 2022 Sep; 13(18):2592-2605. PubMed ID: 35950373
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of kappa opioid receptor promotes ESCC proliferation, invasion and metastasis via the PDK1-AKT signaling pathway.
Huang HM; He XH; Huang XY; Wang GY; Xia QX; Du ZP; Zhang YF
Cell Commun Signal; 2022 Mar; 20(1):35. PubMed ID: 35305679
[TBL] [Abstract][Full Text] [Related]
17. CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway.
He Y; Mingyan E; Wang C; Liu G; Shi M; Liu S
Int J Biol Macromol; 2019 Mar; 125():116-123. PubMed ID: 30508543
[TBL] [Abstract][Full Text] [Related]
18. Homeobox D10, a tumor suppressor, inhibits the proliferation and migration of esophageal squamous cell carcinoma.
Zhang J; Liu S; Zhang D; Ma Z; Sun L
J Cell Biochem; 2019 Aug; 120(8):13717-13725. PubMed ID: 30938888
[TBL] [Abstract][Full Text] [Related]
19. SH2D4A inhibits esophageal squamous cell carcinoma progression through FAK/PI3K/AKT signaling pathway.
Shi H; Luo J; Ye L; Duan C; Zhang M; Ran H; Li C; Wu Q; Shao Y
Cell Signal; 2024 Feb; 114():110997. PubMed ID: 38043670
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
